Villanueva, Jerum Jr. A.
HRN: 23-70-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/17/2023
09/23/2023
IV
160mg
TID
Typhlitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: BloodstreamIntra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes